GlassScriptPhysician profile
Laconte Randle
NPI 1518489186
$2,093.48
in general payments reported to CMS, 2019-2025
10 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $344 · 2023: $936 · 2024: $560 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,749.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $564.67 | 2023-2024 | Farxiga, Airsupra, Fasenra |
| Abbvie INC. | $428.89 | 2022-2024 | |
| Amgen INC. | $274.24 | 2023-2024 | Evenity, Repatha |
| Acadia Pharmaceuticals INC | $196.88 | 2023 | Nuplazid |
| Neurocrine Biosciences, INC. | $125.15 | 2023 | Ongentys |
| Lilly USA, LLC | $125.00 | 2022 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Corcept Therapeutics | $106.49 | 2025 | Korlym |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $86.38 | 2025 | |
| Sanofi-Aventis U.S. LLC | $60.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laconte Randle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.